Read more

May 27, 2020
1 min read
Save

Top in endocrinology: Obesity and COVID-19, telehealth tips

Results of two studies conducted in China showed that obesity may triple the odds of having more severe COVID-19 symptoms. This was the top story in endocrinology last week.

Another top story was about tips for endocrinologists on navigating telehealth visits.

Read these and more of last week’s top stories in endocrinology below:

Obesity triples odds of more severe symptoms with COVID-19

In two cohorts of Chinese adults with COVID-19, those with obesity were at least three times more likely to have a severe case of the disease than those with normal weight, according to two studies published in Diabetes Care. Read more.

Tips for navigating telehealth visits in endocrinology

The COVID-19 pandemic is now in its third month, and providers across the country have worked to smooth out the rough edges of an unprecedented, rapid shift from in-person health care visits to primarily telehealth. For endocrinologists, that shift has meant making adjustments large and small, from delaying lab work and bone density scans to talking a patient through a self-administered thyroid exam. Read more.

Telehealth 
The COVID-19 pandemic is now in its third month, and providers across the country have worked to smooth out the rough edges of an unprecedented, rapid shift from in-person health care visits to primarily telehealth.
Source: Adobe Stock

Mild thyroid variation may predict stroke risk

Minor variations in normal-range thyroid function may serve as a novel, modifiable risk factor for stroke, according to findings from a Mendelian randomization analysis published in The Journal of Clinical Endocrinology & Metabolism. Read more.

Low-dose hCG can prevent sterility in men prescribed testosterone

Low-dose human chorionic gonadotropin, or hCG, may preserve spermatogenesis in men with hypogonadism treated with intramuscular or transdermal testosterone replacement therapy, according to a speaker at the Androgen Society annual meeting. Read more.

Pediatric CGM use improves sleep quality for children, not parents in type 1 diabetes

A small study of young children with type 1 diabetes and their parents suggests that continuous glucose monitoring technology may improve a child’s sleep by minimizing wake periods during the night for blood glucose monitoring, whereas a parent’s sleep may be more disrupted by frequent nighttime blood glucose checks when using CGM, according to findings published in Diabetes Technology & Therapeutics. Read more.